AIDP Announces Sales Agreement for PureMune

City of Industry, CA—AIDP, Inc. has announced an exclusive sales distribution agreement with Immundyne Nutritional. “As AIDP expands our immunity portfolio, we looked for the highest quality ingredients with unique positioning and proven results,” said Mark Thurston, president of AIDP, in a press release. “We are pleased to represent PureMune from Immundyne Nutritional and look forward to presenting it to our customers.”

The Jacksonville, Fl-based Immundyne Nutritional, formulated PureMune—a beta-glucan—to be used as a stand-alone ingredient or used in varieties of combination formulas. Boasting an immune response within 3 hours, PureMune is a nano-particulate and thus insoluble beta-gluten, for improved effectiveness vs. soluble beta-glutens, the company claims.

It exerts its action on the innate immune system by activating all three receptor systems, dectin-1, toll-like receptors, and the complement receptor for enhanced immune modulating properties, the company claims. PureMune’s dose is only 30 mg per day. It is odorless and tasteless and with FDA GRAS status, PureMune is an ideal ingredient for a wide variety of applications, the press release says.

Related: AIDP Partners With Verdant Oasis
#Naturally Informed: Immune Health Supplement Education
AIDP, Keraplast Sign Exclusive Distribution Agreement

“We are excited to partner with AIDP for PureMune,” says Mark McLaughlin, chief executive officer of Immundyne Nutritional. “AIDP’s expertise in providing vetted, high quality and innovative ingredients made them the perfect partner for PureMune. AIDP’s broad customer base along with our novel ingredient creates an ideal partnership for both companies.”